BME Seminar Series: Phenotypic Personalized Medicine (PPM): Applications


3:00 pm-4:00 pm
Add to Outlook/iCal
Add to Google Calendar


Communicore Room C1-17
Gainesville, FL 32611


Ali Zarrinpar, M.D., Ph.D.
Associate Professor
Department of Surgery,
Division of Transplantation & Hepatobiliary
Surgery, Department of Biochemistry and
Molecular Biology, College of Medicine,
University of Florida

This talk provides an overview of applications of
a computational platform (Phenotypic Precision
Medicine) to optimize combination therapy to
markedly enhance efficacy and safety in the
treatment of a variety of diseases of the liver.
These include two independent approaches to
the treatment liver cancer, a leading cause of
cancer death worldwide and the only cancer
whose mortality rate had increased over the
last 10 years. I will also discuss optimization of
immunosuppression after liver transplantation
and fatty liver disease and non-alcoholic

Ali Zarrinpar, M.D., Ph.D., is associate professor in the
Division of Transplantation and Hepatobiliary Surgery
at the University of Florida, College of Medicine.
Dr. Zarrinpar earned his medical degree from the
University of California, San Francisco, where he
also obtained a PhD in biochemistry. He completed
a general surgery residency and a fellowship in
multivisceral transplant and hepatobiliary surgery
from the University of California, Los Angeles. He is
a fellow of the American College of Surgeons and the
American Society of Transplantation. He serves on
the editorial board member of several journals and on
multiple committees in American Society of Transplant
Surgeons, Society for Lab Automation and Screening,
among others. He has won a number of awards,
including from SLAS, ACS, and ASTS. In addition to
his clinical hepatobiliary and transplantation practice,
Zarrinpar has an NIH funded research program in
liver cancer, liver injury/disease, and transplant


Hosted by

Dr. Christine E. Schmidt